| 1. |
Tomoharu Yoshizumi and Masaki Mori, How to Assess the Effects of Different Interventions for Decreasing Blood Loss and Blood Transfusion Requirements During Elective Liver Resection., Indonesian Digestive Surgery Doctors Association, 2021.01. |
| 2. |
Tomoharu Yoshizumi, Masaki Mori, Challenges in the Selection of Marginal Donors in Living Donor Liver Transplantation, 14th World Congress of the IHPBA, 2020.09. |
| 3. |
Tomoharu Yoshizumi, Living Donor Liver Transplantation for HCC, Taiwan Transplant Society, 2019.11. |
| 4. |
Tomoharu Yoshizumi, Masaki Mori
, Surgery for Hepatocellular Carcinoma, Indian Association of Surgical Gastroenterology, Annual Conference 2019, 2019.10. |
| 5. |
Tomoharu Yoshizumi, Masaki Mori
, Long term outcomes of ABO incompatible liver transplant
, 5th CLBS sympojium 2019, 2019.10. |
| 6. |
Tomoharu Yoshizumi, Shinji Itoh, Noboru Harada, Kazuki Takeishi, Shohei Yoshiya, Toru Ikegami, Masaki Mori
, The role of Surgical Treatment for Recurrent Hepatocellular Carcinoma
, 第74回 日本消化器外科学会総会, 2019.07. |
| 7. |
Tomoharu Yoshizumi, Toru Ikegami, Noboru Harada, Shinji Itoh, Kazuki Takeishi, Yohei Mano, Shohei Yoshiya, Takeshi Kurihara, Masaki Mori
, Effect of simultaneous splenectomy in adult living donor liver transplantation analyzed using propensity score matching
, The 31th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2019.06. |
| 8. |
吉住 朋晴, Graft selection strategy in living donor liver transplantation
, Asian Transplantation Week 2016, 2016.10. |
| 9. |
吉住 朋晴, Optimizing Outcomes for HCC after Liver Transplantation, Advances in Liver Transplantation 2014 East Meets West, 2014.11. |
| 10. |
吉住 朋晴, Living Donor Liver Transplantation For Hepatocellular Carcinoma Within Milan Criteria, 9th International conference of anticancer research, 2014.10. |
| 11. |
吉住 朋晴, Impact of Tumor Size, Number of Tumors, Neutrophil-to-lymphocyte ratio and des-gamma-carboxy prothrombin in liver transplantation for hepatocellular carcinoma. , DDW2013, 2013.05. |
| 12. |
Yoshizumi T, Shirabe K, Ikegami T, Harimoto N, Toshima T, Yamashita Y, Ikeda T, Soejima Y, Maehara Y, Impact of human T-cell leukemia virus type 1 in living donor liver transplantation, 第98回ACS, 2012.10. |
| 13. |
Yoshizumi T, Shirabe Ｋ, Ikegami T, Harimoto N, Toshima T, Matsumoto Y, Kimura K, Nakagawara H, Yoshiya S, Yamashita Y, Soejima Y, Maehara Y, Expanded Selection Criteria for Living Donor Liver Transplantation in Patients with Hepatocellular Carcinoma, ILCA, 2012.09. |
| 14. |
Yoshizumi T, Shirabe K, Ikegami T, Yoshiya S, Matono R, Toshima T., Kimura K., Nakagawara H, Matsumoto Y, Kawasaki J, Harimoto N, Yamashita Y, Ikeda T, Soejima Y, Maehara Y, MycophenolateMofetilMonotherapy in Living Donor Liver Transplantation , The 3rd International Conference on Transplantomics and Biomarkers in Organ Transplantation, 2012.03. |
